The VALID-CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real-world population.

ABSTRACT:

Objectives

The aim of the study was to confirm the value of the VALID-cardiac resynchronization therapy (CRT) risk score in predicting outcome and to assess its association with clinical response (CR) in an unselected real-world CRT population.

Methods and results

The present analysis comprised all consecutive CRT patients (pts) enrolled in the CRT-MORE registry from 2011 to 2013. Pts were stratified into five groups (quintiles 1-5) according to the VALID-CRT risk predictor index applied to the CRT-MORE population. In the analysis of clinical outcome, adverse events comprised death from any cause and non-fatal heart failure (HF) events requiring hospitalization. CR at 12-month follow-up was also assessed. We enrolled 905 pts. During a median follow-up of 1005 [627-1361] days

SUBMITTER: Bertaglia E 

PROVIDER: S-EPMC6788573 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature